Transaction · 0001464583-26-000008

Megna Michael R

Megna Michael R, CAO, reported a transaction classified as exercise at Kiniksa Pharmaceuticals International, plc involving 2558.000000 shares. Reported holdings after the transaction were 34187.000000 shares. The stored filing text includes a detected 10b5-1 reference.

exerciseSEC transaction code MCAO
KNSAKiniksa Pharmaceuticals International, plc
Trade date
Sep 01, 2026
Filing date
Sep 03, 2026
View on SEC Insider profile
Estimated value—Shares × reported price
Shares traded2.55kPrice unknown
Holdings after34.1kDirect
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Filing warnings

Notes recorded with this filing
1 warning
missing priceThe filing did not provide a usable price per share.

KNSA price since this filing

Daily closing prices, with the filing date and available return windows
KNSA · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -7.6%1w ago -0.8%1d ago -2.3%
Returns since7d -5.0%30d -5.8%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
exercise
Code M
Identifier
0001464583-26-000008
Class A Ordinary Share
Transaction date
Sep 01, 2026
Filed Sep 03, 2026, 08:40 PM · 2d delay
Shares
2,558 sh
Price unknown
Estimated value
—
Computed from shares × price
Holdings after
34,187 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership 10b5-1 Detected
Filing-only score

-8 points

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 2

    Filing reported within two business days of the transaction.
  • tenb5_1_detected-10 points

    is_10b5_1 = true

    Stored filing content includes detected 10b5-1 language.
  • missing_price-8 points

    price_cents is null

    Missing price reduces confidence in value-based signals.
Missing facts
  • price_cents
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

CHIEF ACCOUNTING OFFICER

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The reporting person is voluntarily reporting the acquisition of these shares pursuant to the Issuer's 2018 Employee Share Purchase Plan for the purchase period of January 16, 2026 to July 15, 2026. T…

  2. F2

    Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.

  3. F3

    This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on May 24, 2025.

  4. F4

    The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2026.

  5. F5

    The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting comme…

  6. F6

    The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2025.

  7. F7

    The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date, September 1, 2024.

  8. F8

    The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2023.

  9. F9

    The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2022.

Original filing · 0001464583-26-000008
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

KNSA